3Chaves F, Alonso-Sanz M, Rebollo MJ, et al. rpoB mutations as an epidemiologic marker in rifampin-resistant mycobacterium tuberculosis. Int J Tuberc Lung Dis,2000,4(8) :765-770.
4Marti TM, Kunz C, Fleck O. DNA mismatch repair and mutation avoidance pathways. J Cell Physiol,2002,191(1) :28-41.
5Bi LJ,Zhou YF,Zhang XE,et al. A MutS-based protein chip for detection of DNA mutations. An Chem,2003,75(16) :4113-4119.
6Ge H. UPA, a universal protein arry system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions. NucleicAcids Res,2000,28(2) :e3.
7Walter G, Bussow K, Cahill D, et al. Protein arrays for gene expression and molecular interaction screening. Curr Opin Microbiol,2000,3(3):298-302.
8Zhu H, Bilgin M,Bangham R,et al. Global analysis of protein activities using proteome chips. Science,2001,293(5537) :2101-2105.
9Neuman de Vegvar HE,Amara RR,Steinman L,et al. Microarray profiling of antibody responses against simian-human immunodeficiency virus:postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen. J Virol,2003,77(20): 11125-11138.
10Panshin A, Shihmanter E, Weisman Y, et al. Antigenic heterogeneity amongst the field isolates of newcastle disease virus (NDV) in relation to the vaccine strain. Part Ⅱ: studies on viruses isolated from domestic binds in Israel. Comp Immunol Microbiol Infect Dis,2002,25(3): 173-185.
